INSPECS Group plc (AIM:SPEC)
London · Delayed Price · Currency is GBP · Price in GBX 100.00
+4.00 (4.17%)
Sep 18, 2026, 3:01 PM GMT
INSPECS Group Market Cap
INSPECS Group has a market cap or net worth of 104.81 million as of September 18, 2026. Its market cap has increased by 139.73% in one year.
Market Cap
104.81M
Enterprise Value
133.72M
Revenue
193.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
100.00
ChartMarket Cap Chart
Since February 27, 2020, INSPECS Group's market cap has decreased from 137.95M to 104.81M, a decrease of -24.03%. That is a compound annual growth rate of -4.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 104.81M | 44.17% |
| Dec 31, 2025 | 72.70M | 57.14% |
| Dec 31, 2024 | 46.26M | -45.83% |
| Dec 29, 2023 | 85.40M | 95.35% |
| Dec 30, 2022 | 43.72M | -88.33% |
| Dec 31, 2021 | 374.78M | 12.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.88B |
| GSK plc | 75.23B |
| Haleon | 30.01B |
| Smith & Nephew | 8.64B |
| Diaceutics | 144.30M |
| AOTI, Inc. | 138.27M |
| Scancell Holdings | 118.19M |
| EKF Diagnostics Holdings | 111.34M |